chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Mass, Pain in extremity, Vaccination site pain
Clinical narrative: hurts; hurt a little more than the first shot/ Maybe he damaged my muscles; knot in my arm; This spontaneous case was reported by a consumer and describes the occurrence of MASS (knot in my arm), PAIN IN EXTREMITY (hurts) and VACCINATION SITE PAIN (hurt a little more than the first shot/ Maybe he damaged my muscles) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A, 060H21A and 002A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In March 2021, the patient experienced MASS (knot in my arm). On an unknown date, the patient experienced PAIN IN EXTREMITY (hurts) and VACCINATION SITE PAIN (hurt a little more than the first shot/ Maybe he damaged my muscles). At the time of the report, MASS (knot in my arm) and PAIN IN EXTREMITY (hurts) had not resolved and VACCINATION SITE PAIN (hurt a little more than the first shot/ Maybe he damaged my muscles) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported. It was reported that vaccine was supposed to be administered at 90 degree angle and was given at 30 degree angle. Patient experienced pain and reported that was not sure whether his muscles were damaged.   This case was linked to MOD-2021-416062 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: I'm sore; This spontaneous case was reported by an other health care professional and describes the occurrence of MYALGIA (I'm sore) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In December 2021, the patient experienced MYALGIA (I'm sore). At the time of the report, MYALGIA (I'm sore) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment medications were not reported.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Neuropathic pruritus, Paraesthesia, Vaccination site pain
Clinical narrative: had a neuropathic itch on sole of left foot. Not a regular itch.; Like pins; very annoying; Nothing at the injection site except sore; This spontaneous case was reported by a pharmacist and describes the occurrence of NEUROPATHIC PRURITUS (had a neuropathic itch on sole of left foot. Not a regular itch. ), PARAESTHESIA (Like pins), FEELING ABNORMAL (very annoying) and VACCINATION SITE PAIN (Nothing at the injection site except sore) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031H21A, 017B21A and 011J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Dec-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (Nothing at the injection site except sore). On 13-Dec-2021, the patient experienced NEUROPATHIC PRURITUS (had a neuropathic itch on sole of left foot. Not a regular itch. ), PARAESTHESIA (Like pins) and FEELING ABNORMAL (very annoying). At the time of the report, NEUROPATHIC PRURITUS (had a neuropathic itch on sole of left foot. Not a regular itch. ), PARAESTHESIA (Like pins), FEELING ABNORMAL (very annoying) and VACCINATION SITE PAIN (Nothing at the injection site except sore) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient denied to provide concomitant medications.  The patient received the booster of the Moderna COVID-19 vaccine in the left upper arm.   The patient had no rash. The reactions came and went. The patient did not receive any treatments but planning to take Allegra.   This case was linked to MOD-2021-416481, MOD-2021-416488 (Patient Link).
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Immune system disorder, Pyrexia, Rash, Urticaria
Clinical narrative: immune system is going berserk; It comes & goes, moves around her body, & comes in clusters; A slight rise in body temperature triggers the rash; urticaria; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (urticaria), IMMUNE SYSTEM DISORDER (immune system is going berserk), RASH (It comes & goes, moves around her body, & comes in clusters) and PYREXIA (A slight rise in body temperature triggers the rash) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 030L20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (sulfa allergy).   On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2021, the patient experienced URTICARIA (urticaria). On an unknown date, the patient experienced IMMUNE SYSTEM DISORDER (immune system is going berserk), RASH (It comes & goes, moves around her body, & comes in clusters) and PYREXIA (A slight rise in body temperature triggers the rash). The patient was treated with HYDROCORTISONE for Adverse event, at a dose of 1 dosage form; OMALIZUMAB (XOLAIR) for Adverse event, at a dose of 1 dosage form and CAMPHOR, MENTHOL, PHENOL (SARNA [CAMPHOR;MENTHOL;PHENOL]) for Adverse event, at a dose of 1 dosage form. At the time of the report, URTICARIA (urticaria) had not resolved and IMMUNE SYSTEM DISORDER (immune system is going berserk), RASH (It comes & goes, moves around her body, & comes in clusters) and PYREXIA (A slight rise in body temperature triggers the rash) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: decreased (Low) Checked the allergic reactivity which showed the intensity of the outbreaks are decreasing..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was provided by the reporter.  Patient was also treating with antihistamines orally, she is also going to try acupuncture. Rash will stay in place for 5 to 10days and comes back somewhere else.
Sex: M
Vaccine: COVID19
Symptoms: Muscle spasms
Clinical narrative: cramping in hands, not able to hold a pen; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (cramping in hands, not able to hold a pen) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCLE SPASMS (cramping in hands, not able to hold a pen). At the time of the report, MUSCLE SPASMS (cramping in hands, not able to hold a pen) outcome was unknown.            No concomitant medication were reported. No treatment medication were reported.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Interchange of vaccine products
Clinical narrative: first dose > 25 days ago; first dose was not an approved or authorized COVID19 Vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (first dose was not an approved or authorized COVID19 Vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose > 25 days ago) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 3002914) for COVID-19 vaccination.     Previously administered products included for COVID-19 vaccination: AstraZeneca (first dose and Lot MT0055) on 20-Apr-2021. Past adverse reactions to the above products included No adverse event with AstraZeneca.    On 15-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (first dose was not an approved or authorized COVID19 Vaccine). On 15-Jun-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose > 25 days ago). On 20-Apr-2021, INTERCHANGE OF VACCINE PRODUCTS (first dose was not an approved or authorized COVID19 Vaccine) had resolved. On 15-Jun-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose > 25 days ago) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Breast cancer
Clinical narrative: She has breast cancer right now; This spontaneous case was reported by a consumer and describes the occurrence of BREAST CANCER (She has breast cancer right now) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BREAST CANCER (She has breast cancer right now) (seriousness criterion medically significant). At the time of the report, BREAST CANCER (She has breast cancer right now) outcome was unknown.            Concomitant medications were not reported . Treatment information was not provided. The patient was due for surgery in 4 to 6 weeks for surgery.  Company comment: This is a spontaneous case concerning an unknown age female patient with no  medical history reported, who experienced the  serious (due to medically important condition) unexpected , according to, event of Breast cancer. Event onset of the event is not provided. The rechallenge was not applicable. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This is a spontaneous case concerning an unknown age female patient with no  medical history reported, who experienced the  serious (due to medically important condition) unexpected , according to, event of Breast cancer. Event onset of the event is not provided. The rechallenge was not applicable. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: received second dose >37 days after first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received second dose >37 days after first dose) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received second dose >37 days after first dose). On 31-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received second dose >37 days after first dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication reported. No treatment information was provided.   This case was linked to MOD-2021-416481, MOD-2021-416211 (Patient Link).
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was administered an expired booster dose of Moderna COVID-19 vaccine.; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered an expired booster dose of Moderna COVID-19 vaccine.) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027H21B, 030L20A and 037K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered an expired booster dose of Moderna COVID-19 vaccine.). On 17-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Patient was administered an expired booster dose of Moderna COVID-19 vaccine.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant drug details were reported. No treatment details were reported.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Dizziness, Fatigue, Myalgia, Somnolence
Clinical narrative: eye vision started to blur; anxiety; dizzy; super tired; achy; slept for two days; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (eye vision started to blur), ANXIETY (anxiety), SOMNOLENCE (slept for two days), DIZZINESS (dizzy) and FATIGUE (super tired) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Anxiety, Nausea, Acid reflux (esophageal) and Migraine. Concomitant products included OMEPRAZOLE for Acid reflux (esophageal), RIZATRIPTAN for Migraine, ONDANSETRON for Nausea, SERTRALINE and ALPRAZOLAM for an unknown indication.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, the patient experienced VISION BLURRED (eye vision started to blur), ANXIETY (anxiety) and DIZZINESS (dizzy). In April 2021, the patient experienced SOMNOLENCE (slept for two days), FATIGUE (super tired) and MYALGIA (achy). The patient was treated with NAPROXEN for Adverse event, at an unspecified dose and frequency. On 12-Apr-2021, VISION BLURRED (eye vision started to blur) and DIZZINESS (dizzy) had resolved. At the time of the report, ANXIETY (anxiety), SOMNOLENCE (slept for two days), FATIGUE (super tired) and MYALGIA (achy) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-416931 (Patient Link).
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: eye vision started to blur; anxiety; dizzy; super tired; achy; slept for two days; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (eye vision started to blur), ANXIETY (anxiety), SOMNOLENCE (slept for two days), DIZZINESS (dizzy) and FATIGUE (super tired) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Anxiety, Nausea, Acid reflux (esophageal) and Migraine. Concomitant products included OMEPRAZOLE for Acid reflux (esophageal), RIZATRIPTAN for Migraine, ONDANSETRON for Nausea, SERTRALINE and ALPRAZOLAM for an unknown indication.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, the patient experienced VISION BLURRED (eye vision started to blur), ANXIETY (anxiety) and DIZZINESS (dizzy). In April 2021, the patient experienced SOMNOLENCE (slept for two days), FATIGUE (super tired) and MYALGIA (achy). The patient was treated with NAPROXEN for Adverse event, at an unspecified dose and frequency. On 12-Apr-2021, VISION BLURRED (eye vision started to blur) and DIZZINESS (dizzy) had resolved. At the time of the report, ANXIETY (anxiety), SOMNOLENCE (slept for two days), FATIGUE (super tired) and MYALGIA (achy) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-416931 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site inflammation
Clinical narrative: a great inflammation under her right armpit were she got her vaccination; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INFLAMMATION (a great inflammation under her right armpit were she got her vaccination) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Dec-2021, the patient experienced VACCINATION SITE INFLAMMATION (a great inflammation under her right armpit were she got her vaccination). At the time of the report, VACCINATION SITE INFLAMMATION (a great inflammation under her right armpit were she got her vaccination) outcome was unknown.            Concomitant drugs were not reported. Treatment medications were not provided
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Headache
Clinical narrative: felt like garbage/experienced usual; headache; rundown; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt like garbage/experienced usual), HEADACHE (headache) and FATIGUE (rundown) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21-2A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PROBIOTICS NOS and VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (felt like garbage/experienced usual), HEADACHE (headache) and FATIGUE (rundown). At the time of the report, FEELING ABNORMAL (felt like garbage/experienced usual), HEADACHE (headache) and FATIGUE (rundown) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Treatment information was not provided.   This case was linked to MOD-2021-416976, MOD-2021-416979 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Pain in extremity
Clinical narrative: She had a sore arm; At the third day she had problems breathing; She was very tired the next day,exhausted even; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (She had a sore arm), DYSPNOEA (At the third day she had problems breathing) and FATIGUE (She was very tired the next day,exhausted even) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (She had a sore arm), DYSPNOEA (At the third day she had problems breathing) and FATIGUE (She was very tired the next day,exhausted even). On 19-Dec-2021, DYSPNOEA (At the third day she had problems breathing) had resolved. At the time of the report, PAIN IN EXTREMITY (She had a sore arm) and FATIGUE (She was very tired the next day,exhausted even) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant and Treatment medication were reported.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Pain
Clinical narrative: felt worse and worse; experienced anxiety within 20 minutes and it lasted for hours and hours; body hurt so bad couldn't stand up straight; achiness in heart and chest and this went on for about 3 to 4 days; no appetite; body hurt so bad thet the patient couldn't stand up straight; chronic fatigue; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (achiness in heart and chest and this went on for about 3 to 4 days), ANXIETY (experienced anxiety within 20 minutes and it lasted for hours and hours), DYSSTASIA (body hurt so bad couldn't stand up straight), FEELING ABNORMAL (felt worse and worse) and DECREASED APPETITE (no appetite) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025C21A and 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Anxiety (takes sertraline and alprazolam), Nausea, Acid reflux (esophageal) and Migraine. Concomitant products included OMEPRAZOLE for Acid reflux (esophageal), SERTRALINE and ALPRAZOLAM for Anxiety, RIZATRIPTAN for Migraine, ONDANSETRON for Nausea.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-May-2021, the patient experienced ANXIETY (experienced anxiety within 20 minutes and it lasted for hours and hours). On 11-May-2021, the patient experienced FEELING ABNORMAL (felt worse and worse). In May 2021, the patient experienced CHEST PAIN (achiness in heart and chest and this went on for about 3 to 4 days), DYSSTASIA (body hurt so bad couldn't stand up straight), DECREASED APPETITE (no appetite), PAIN (body hurt so bad thet the patient couldn't stand up straight) and FATIGUE (chronic fatigue). The patient was treated with NAPROXEN for Adverse event, at an unspecified dose and frequency. In May 2021, CHEST PAIN (achiness in heart and chest and this went on for about 3 to 4 days), ANXIETY (experienced anxiety within 20 minutes and it lasted for hours and hours), DYSSTASIA (body hurt so bad couldn't stand up straight), FEELING ABNORMAL (felt worse and worse), DECREASED APPETITE (no appetite), PAIN (body hurt so bad thet the patient couldn't stand up straight) and FATIGUE (chronic fatigue) had resolved.            Patient reported of having no noted heart conditions but had other medical issues that had not been properly diagnosed and treated for.  Patient experienced anxiety within 20 minutes after vaccination and it lasted for hours and hours. And 24 hours later, the patient felt worse and worse, and 20 to 36 hours later, the patient's body hurt so bad that the patient could not stand up straight, chronic fatigue, no appetite, achiness in heart and chest and this went on for about 3 to 4 days and subsided upto 8 days. Patient has not tested positive for COVID-19.   This case was linked to MOD-2021-416922 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administered Moderna vaccine after the beyond-use-date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered Moderna vaccine after the beyond-use-date) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered Moderna vaccine after the beyond-use-date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered Moderna vaccine after the beyond-use-date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported by reporter No treatment medications provided by the reporter.   Reporter administered some Moderna vaccines after the beyond-use-date, after the 30 days.   Most recent FOLLOW-UP information incorporated above includes: On 20-Dec-2021: Follow up received-batch number updated.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Calling about an adverse reaction to the Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Calling about an adverse reaction to the Moderna vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.  No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Calling about an adverse reaction to the Moderna vaccine). At the time of the report, VACCINATION COMPLICATION (Calling about an adverse reaction to the Moderna vaccine) outcome was unknown.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.    No concomitant medications were reported. No treatment details were reported.
Sex: U
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal, Inappropriate schedule of product administration, Palpitations
Clinical narrative: Heart has been racing out of my chest; Feeling real bad; Getting real dizzy; Inappropriate schedule of vaccine administered (1 Dose- 31 August 2021 2 Dose-  09 December 2021); This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Heart has been racing out of my chest), FEELING ABNORMAL (Feeling real bad), DIZZINESS (Getting real dizzy) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered (1 Dose- 31 August 2021 2 Dose-  09 December 2021)) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Heart disease, unspecified (Already gotten two different heart diseases).   On 31-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Dec-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Dec-2021, the patient experienced PALPITATIONS (Heart has been racing out of my chest), FEELING ABNORMAL (Feeling real bad), DIZZINESS (Getting real dizzy) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered (1 Dose- 31 August 2021 2 Dose-  09 December 2021)). On 09-Dec-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered (1 Dose- 31 August 2021 2 Dose-  09 December 2021)) had resolved. At the time of the report, PALPITATIONS (Heart has been racing out of my chest), FEELING ABNORMAL (Feeling real bad) and DIZZINESS (Getting real dizzy) had not resolved.            No concomitant medications were mentioned. No treatment details were reported.
Sex: U
Vaccine: COVID19
Symptoms: Pharyngeal swelling, Pruritus, Throat tightness, Tongue pruritus, Urticaria
Clinical narrative: itchiness; ultimately developing hives; itchy tongue; swelling and tightness of my throat; swelling and tightness of my throat; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchiness), URTICARIA (ultimately developing hives), TONGUE PRURITUS (itchy tongue), PHARYNGEAL SWELLING (swelling and tightness of my throat) and THROAT TIGHTNESS (swelling and tightness of my throat) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Dec-2021, the patient experienced PRURITUS (itchiness), URTICARIA (ultimately developing hives), TONGUE PRURITUS (itchy tongue), PHARYNGEAL SWELLING (swelling and tightness of my throat) and THROAT TIGHTNESS (swelling and tightness of my throat). At the time of the report, PRURITUS (itchiness), URTICARIA (ultimately developing hives), TONGUE PRURITUS (itchy tongue), PHARYNGEAL SWELLING (swelling and tightness of my throat) and THROAT TIGHTNESS (swelling and tightness of my throat) outcome was unknown.            No concomitant medication was reported.  No treatment medication use was reported.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Irritability, Pruritus, Swelling, Vaccination complication
Clinical narrative: Suffering after booster; Swelling all over her body after booster; Itching all over her body after booster; Irritated after booster; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Suffering after booster), SWELLING (Swelling all over her body after booster), PRURITUS (Itching all over her body after booster) and IRRITABILITY (Irritated after booster) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032H21A, 013L20A and 030M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Dec-2021, the patient experienced VACCINATION COMPLICATION (Suffering after booster), SWELLING (Swelling all over her body after booster), PRURITUS (Itching all over her body after booster) and IRRITABILITY (Irritated after booster). At the time of the report, VACCINATION COMPLICATION (Suffering after booster), SWELLING (Swelling all over her body after booster), PRURITUS (Itching all over her body after booster) and IRRITABILITY (Irritated after booster) had not resolved.            Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.   This case was linked to MOD-2021-416977, MOD-2021-416984 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: has Tinnitus real bad about a month after the covid Moderna shot; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (has Tinnitus real bad about a month after the covid Moderna shot) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, the patient experienced TINNITUS (has Tinnitus real bad about a month after the covid Moderna shot). At the time of the report, TINNITUS (has Tinnitus real bad about a month after the covid Moderna shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by reporter No treatment medications provided by the reporter.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm for a couple of days; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm for a couple of days) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     Concurrent medical conditions included Anxiety. Concomitant products included TROSPIUM for Anxiety, PANTOPRAZOLE SODIUM, ATORVASTATIN and VITAMINS NOS for an unknown indication.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm for a couple of days). At the time of the report, PAIN IN EXTREMITY (sore arm for a couple of days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were reported.   This case was linked to MOD-2021-416948, MOD-2021-416968 (Patient Link).
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Pruritus, Skin irritation
Clinical narrative: skin irritation; palm of her hands and bottom of feet feels like its burning; patches of itchy spots; This spontaneous case was reported by a consumer and describes the occurrence of SKIN IRRITATION (skin irritation), BURNING SENSATION (palm of her hands and bottom of feet feels like its burning) and PRURITUS (patches of itchy spots) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 067F1A, 042B21-2A and 022C1A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In December 2021, the patient experienced SKIN IRRITATION (skin irritation), BURNING SENSATION (palm of her hands and bottom of feet feels like its burning) and PRURITUS (patches of itchy spots). At the time of the report, SKIN IRRITATION (skin irritation), BURNING SENSATION (palm of her hands and bottom of feet feels like its burning) and PRURITUS (patches of itchy spots) outcome was unknown.            No concomitant medication details was reported. The patient states a week or two after the booster she had skin irritation. The palm of her hands and bottom of feet feels like its burning. She had patches of itchy spots. No treatment medication details was reported.   This case was linked to MOD-2021-417848 (Patient Link).
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Illness, Loss of personal independence in daily activities, Pain
Clinical narrative: feeling very sick; feeling very bad; being hurt in bed/aches; can't do anything; chills; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (feeling very sick), FEELING ABNORMAL (feeling very bad), PAIN (being hurt in bed/aches), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (can't do anything) and CHILLS (chills) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022c21a, 001r21a and 031m2a) for COVID-19 vaccination.     Concomitant products included MELOXICAM and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Dec-2021, the patient experienced ILLNESS (feeling very sick), FEELING ABNORMAL (feeling very bad), PAIN (being hurt in bed/aches), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (can't do anything) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. At the time of the report, ILLNESS (feeling very sick), FEELING ABNORMAL (feeling very bad), PAIN (being hurt in bed/aches), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (can't do anything) and CHILLS (chills) had not resolved.            Concomitant medications included cholesterol medication, blood pressure medication and regular medication.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: after first and second dose sore arm for a couple of days; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (after first and second dose sore arm for a couple of days) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     Concomitant products included TROSPIUM for Anxiety, PANTOPRAZOLE SODIUM, ATORVASTATIN and VITAMINS NOS for an unknown indication.    On 27-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (after first and second dose sore arm for a couple of days). At the time of the report, PAIN IN EXTREMITY (after first and second dose sore arm for a couple of days) outcome was unknown.            Treatment details was not reported by the reporter.   This case was linked to MOD-2021-416959, MOD-2021-416948 (Patient Link).
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: having a shingles outbreak; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (having a shingles outbreak) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Shingles (Shingles outbreak in October or November 2020 and then she started to have a couple more ever since.) in 2020. Concomitant products included LORATADINE (CLARITIN [LORATADINE]), IBUPROFEN and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced HERPES ZOSTER (having a shingles outbreak). The patient was treated with VALACYCLOVIR [VALACICLOVIR] on 17-Dec-2021 for Shingles, at an unspecified dose and frequency. At the time of the report, HERPES ZOSTER (having a shingles outbreak) had not resolved.            It was reported that patient was on second day of Valacyclovir.
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain
Clinical narrative: experiencing a lot of pain; legs feel numb from the pain; This spontaneous case was reported by a nurse and describes the occurrence of PAIN (experiencing a lot of pain) and HYPOAESTHESIA (legs feel numb from the pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In December 2021, the patient experienced PAIN (experiencing a lot of pain) and HYPOAESTHESIA (legs feel numb from the pain). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Pain, at an unspecified dose and frequency. At the time of the report, PAIN (experiencing a lot of pain) and HYPOAESTHESIA (legs feel numb from the pain) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported. Treatment also included hot water bottle   Reporter did not allow further contact
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Accidental underdose, Extra dose administered
Clinical narrative: The patient came back on 13Dec2021 and received another booster dose; Administration of lower dose than recommended; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (Administration of lower dose than recommended) and EXTRA DOSE ADMINISTERED (The patient came back on 13Dec2021 and received another booster dose) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 103F21A, 032L20A, 011A21A and 058H21A) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised. Concomitant products included OMEPRAZOLE, URSODEOXYCHOLIC ACID (URSODIOL), VEDOLIZUMAB (ENTYVIO), METOPROLOL, MESALAZINE (MESALAMINE), ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), CETIRIZINE and AMLODIPINE for an unknown indication.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 ml. On 13-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 ml. On 06-Dec-2021, the patient experienced ACCIDENTAL UNDERDOSE (Administration of lower dose than recommended). On 13-Dec-2021, the patient experienced EXTRA DOSE ADMINISTERED (The patient came back on 13Dec2021 and received another booster dose). On 06-Dec-2021, ACCIDENTAL UNDERDOSE (Administration of lower dose than recommended) had resolved. On 13-Dec-2021, EXTRA DOSE ADMINISTERED (The patient came back on 13Dec2021 and received another booster dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The caller reported that an immunocompromised patient received the Booster dose (0.25ml) of the Moderna Covid-19 Vaccine, but should have received the third dose instead (0.5ml). The patient came back one week later and received another booster dose (0.25ml).  No Treatment medication was reported.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Pyrexia
Clinical narrative: headache; fever; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) and PYREXIA (fever) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PROBIOTICS NOS and VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 28-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache) and PYREXIA (fever). At the time of the report, HEADACHE (headache) and PYREXIA (fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Body temperature: elevated (High) elevated temp..         No treatment information was provided.   This case was linked to MOD-2021-416924 (Patient Link).
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity, Pyrexia
Clinical narrative: Arm Pain after2nd shot; Headache after2nd shot; Fever after2nd shot; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm Pain after2nd shot), HEADACHE (Headache after2nd shot) and PYREXIA (Fever after2nd shot) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A, 013L20A and 032H21A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm Pain after2nd shot), HEADACHE (Headache after2nd shot) and PYREXIA (Fever after2nd shot). On 13-Feb-2021, PAIN IN EXTREMITY (Arm Pain after2nd shot), HEADACHE (Headache after2nd shot) and PYREXIA (Fever after2nd shot) had resolved.            Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.   This case was linked to MOD-2021-416954, MOD-2021-416984 (Patient Link).
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Dermatitis, Urticaria
Clinical narrative: Daily hives on the back of her head and neck/ tiny hives in weird places; Skin inflamed; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Daily hives on the back of her head and neck/ tiny hives in weird places) and DERMATITIS (Skin inflamed) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046B21A and 008B21-2A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included PROBIOTICS NOS and COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, the patient experienced URTICARIA (Daily hives on the back of her head and neck/ tiny hives in weird places) and DERMATITIS (Skin inflamed). The patient was treated with LEVOCETIRIZINE DIHYDROCHLORIDE (XYZAL) ongoing since an unknown date at a dose of 1 dosage form twice a day. At the time of the report, URTICARIA (Daily hives on the back of her head and neck/ tiny hives in weird places) had not resolved and DERMATITIS (Skin inflamed) outcome was unknown.            Patient stated that a week after hives she had a dental procedure done and they put her on a steroid Dexamethasone and she thought it would help the hives too but it did not help or change after.   This case was linked to MOD-2021-416924, MOD-2021-416976 (Patient Link).
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity, Pyrexia
Clinical narrative: Arm Pain; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm Pain), HEADACHE (Headache) and PYREXIA (Fever) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm Pain), HEADACHE (Headache) and PYREXIA (Fever). On 16-Jan-2021, PAIN IN EXTREMITY (Arm Pain), HEADACHE (Headache) and PYREXIA (Fever) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No Concomitant Drug details were reported.  No Treatment information was provided.   This case was linked to MOD-2021-416954, MOD-2021-416977 (Patient Link).